Antibodies News and Research

RSS

Biotium introduces new line of antibodies for exosome detection

ExoBrite™ Antibody Conjugates are validated and optimized for bright and specific detection of exosome markers CD9, CD63, and CD81 for flow cytometry and western blotting.

20 Jul 2022

Neutralizing activity of skin-patch delivered subunit vaccine against SARS-CoV-2 variants

A new study involved an analysis of the serum from a previous study to determine neutralizing activity against new variants.

20 Jul 2022

Researchers report the detection of viral mutations associated with drug resistance in patients treated with REGEN-COV and sotrovimab

Researchers reported mutations in SARS-CoV-2 Delta and Omicron variants of concern infection cases treated with neutralizing monoclonal antibodies.

20 Jul 2022

The durability of immunity and the likelihood of breakthrough infections following vaccination with four well-studied COVID-19 vaccines

Researchers compared the durability of vaccine-induced immunity and natural infection against COVID-19.

20 Jul 2022

Combinations of broadly neutralizing antibodies may be a more effective approach to treat HIV

Carefully designed cocktails of broadly neutralizing antibodies (bNAbs) could help treat HIV while minimizing the risk of the virus escaping treatment, suggests a study published today in eLife.

20 Jul 2022

Safety and immunogenicity of Moderna vaccines containing mRNA encoding the spike protein of different SARS-CoV-2 strains

Researchers evaluated the safety and immunogenicity of COVID-19 vaccines against SARS-CoV-2 variants of concern.

20 Jul 2022

Study shows Omicron BA.4/5 infection triggers highly cross-reactive neutralizing antibodies

Researchers compared the levels of cross-reactive neutralizing antibodies elicited by SARS-CoV-2 Omicron BA.4 and BA.1 infections.

20 Jul 2022

What is the association between natural killer cell dysfunction and COVID-19 disease severity?

Researchers assessed the association between natural killer cell dysfunction and COVID-19 disease severity.

20 Jul 2022

Omicron-specific mRNA vaccine provides superior immune protection against two viral subvariants

Yale scientists have developed a novel Omicron-specific mRNA vaccine that offers superior immune protection against two viral subvariants than standard mRNA vaccines.

20 Jul 2022

New way to test vaccines may be as rigorous and stringent as exposure to field strains of malaria

Malaria is the deadliest mosquito-borne parasitic infection of humans. In 2021, after a century of research, the World Health Organization (WHO) approved the world's first malaria vaccine.

20 Jul 2022

COVID-19 vaccine-boosted neutralizing antibody levels decrease substantially within 3 months

Although COVID-19 booster vaccinations in adults elicit high levels of neutralizing antibodies against the Omicron variant of SARS-CoV-2, antibody levels decrease substantially within 3 months, according to new clinical trial data.

19 Jul 2022

Gut-lung axis: Using commensal bacteria to reinforce mucosal immunity

A recent study discusses the use of commensal bacteria in the gut and/or respiratory tract to deliver viral antigens to the host, thus acting as vaccines

19 Jul 2022

New data shows the substantial protection offered by third and fourth COVID-19 vaccine doses

A third and fourth COVID-19 vaccine dose offered substantial protection among adults with healthy immune systems who were eligible to receive them during Omicron variant evolution in early 2022, according to a new MMWR published today.

19 Jul 2022

UT Southwestern physicians outline the risks of pregnancy in women with rheumatic disease

Pregnant women with active rheumatic disease carry a higher risk of adverse outcomes than the general population including hypertension, preeclampsia, higher cesarean section rate, small for gestational aged infants, preterm delivery, and fetal loss. To

19 Jul 2022

What is the impact of SARS-CoV-2 variant booster vaccinations?

Researchers conducted preliminary assessments of a booster vaccination with the SARS-CoV-2 variant vaccines.

19 Jul 2022

Should siRNA-based antivirals be added to the COVID toolbox?

A recent study reviewed the existing treatment modalities, including vaccines and antivirals, for SARS-CoV-2 infection.

19 Jul 2022

Sex matters when it comes to immune responses to vaccines and viral infections

A review published in Frontiers in Aging analyzed the sex differences in the safety, effectiveness, and immunogenicity of influenza and COVID-19 vaccines in older individuals. It also analyzed the way sex brings about the modification of the impact of age-related factors on vaccination.

18 Jul 2022

Antibodies News and Research

Biotium introduces new line of antibodies for exosome detection

Neutralizing activity of skin-patch delivered subunit vaccine against SARS-CoV-2 variants

Researchers report the detection of viral mutations associated with drug resistance in patients treated with REGEN-COV and sotrovimab

The durability of immunity and the likelihood of breakthrough infections following vaccination with four well-studied COVID-19 vaccines

Combinations of broadly neutralizing antibodies may be a more effective approach to treat HIV

Safety and immunogenicity of Moderna vaccines containing mRNA encoding the spike protein of different SARS-CoV-2 strains

Study shows Omicron BA.4/5 infection triggers highly cross-reactive neutralizing antibodies

What is the association between natural killer cell dysfunction and COVID-19 disease severity?

Omicron-specific mRNA vaccine provides superior immune protection against two viral subvariants

New way to test vaccines may be as rigorous and stringent as exposure to field strains of malaria

COVID-19 vaccine-boosted neutralizing antibody levels decrease substantially within 3 months

Gut-lung axis: Using commensal bacteria to reinforce mucosal immunity

New data shows the substantial protection offered by third and fourth COVID-19 vaccine doses

UT Southwestern physicians outline the risks of pregnancy in women with rheumatic disease

What is the impact of SARS-CoV-2 variant booster vaccinations?

Should siRNA-based antivirals be added to the COVID toolbox?

Sex matters when it comes to immune responses to vaccines and viral infections

What is the impact of lower COVID-19 vaccine doses in younger cohorts?

How effective is previous infection in preventing reinfection with Omicron BA.4/BA.5?

Scientists evaluate immunostimulatory glycolipid against SARS-CoV-2 infection

A new way of characterising biomolecules eBook

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Automating research - solutions and best practices

Latest Life Science News